Keji Xie

888 total citations
36 papers, 532 citations indexed

About

Keji Xie is a scholar working on Urology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Keji Xie has authored 36 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Urology, 17 papers in Rheumatology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Keji Xie's work include Urinary Bladder and Prostate Research (16 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Pelvic floor disorders treatments (11 papers). Keji Xie is often cited by papers focused on Urinary Bladder and Prostate Research (16 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Pelvic floor disorders treatments (11 papers). Keji Xie collaborates with scholars based in China, United States and Sweden. Keji Xie's co-authors include Ping Tang, Wenjun Yang, Hui Chen, Tianxin Lin, Matthew A. Uhlman, Pengfei Diao, Meng You, Yao Kong, Bowen Gao and Changhao Chen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Urology.

In The Last Decade

Keji Xie

35 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keji Xie China 13 267 178 155 144 97 36 532
Sahyun Pak South Korea 13 203 0.8× 87 0.5× 77 0.5× 89 0.6× 88 0.9× 35 385
Yen-Hwa Chang Taiwan 13 243 0.9× 118 0.7× 59 0.4× 183 1.3× 309 3.2× 40 607
Xiong‐Lin Sun China 12 119 0.4× 68 0.4× 39 0.3× 99 0.7× 94 1.0× 28 303
T Zwergel Germany 13 279 1.0× 67 0.4× 77 0.5× 245 1.7× 88 0.9× 36 553
Maximilian Pallauf Austria 12 245 0.9× 72 0.4× 38 0.2× 99 0.7× 149 1.5× 57 447
Mazen A. Ghanem Egypt 11 140 0.5× 103 0.6× 37 0.2× 200 1.4× 52 0.5× 24 375
Shinji Kurosaka Japan 14 185 0.7× 38 0.2× 26 0.2× 123 0.9× 93 1.0× 29 406
Kazuaki Machioka Japan 9 149 0.6× 36 0.2× 53 0.3× 70 0.5× 48 0.5× 14 321
Youyi Lu China 12 117 0.4× 52 0.3× 21 0.1× 192 1.3× 178 1.8× 31 485
Tomoya Fukawa Japan 11 104 0.4× 34 0.2× 35 0.2× 164 1.1× 116 1.2× 62 392

Countries citing papers authored by Keji Xie

Since Specialization
Citations

This map shows the geographic impact of Keji Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keji Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keji Xie more than expected).

Fields of papers citing papers by Keji Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keji Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keji Xie. The network helps show where Keji Xie may publish in the future.

Co-authorship network of co-authors of Keji Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Keji Xie. A scholar is included among the top collaborators of Keji Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keji Xie. Keji Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jingtong, Qianghua Zhou, Keji Xie, et al.. (2021). Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer. Journal of Experimental & Clinical Cancer Research. 40(1). 203–203. 57 indexed citations
2.
Xie, Keji, et al.. (2020). Successful treatment of encrusted cystitis: A case report and review of literature. World Journal of Clinical Cases. 8(18). 4234–4244. 2 indexed citations
3.
Xie, Keji, et al.. (2019). Self-Care and Quality of Life in Elderly Chinese Patients with Benign Prostatic Hyperplasia. Nursing Science Quarterly. 33(1). 79–84. 6 indexed citations
4.
Yang, Wenjun, et al.. (2019). Distributions and characteristics of initial PSA and PSA velocity in Chinese men aged 50 years and younger without prostate cancer: a multi-center study.. PubMed. 24(2). 832–837. 1 indexed citations
5.
Liao, Limin, Ben Wan, Wei Li, et al.. (2016). Results of a randomized, double‐blind, active‐controlled clinical trial with propiverine extended release 30 mg in patients with overactive bladder. British Journal of Urology. 119(1). 148–157. 3 indexed citations
6.
Zhou, Ping, Matthew A. Uhlman, Pengfei Diao, et al.. (2015). Plasma proteasomal chymotrypsin-like activity correlates with prostate cancer progression. Tumor Biology. 36(6). 4115–4121. 6 indexed citations
7.
8.
Zhou, Ping, et al.. (2014). MLN2238 synergizes BH3 mimetic ABT-263 in castration-resistant prostate cancer cells by induction of NOXA. Tumor Biology. 35(10). 10213–10221. 9 indexed citations
9.
Wu, Yuexian, et al.. (2014). Cystitis glandularis: A controversial premalignant lesion. Oncology Letters. 8(4). 1662–1664. 22 indexed citations
10.
11.
Tang, Ping, et al.. (2013). Prostate volume as an independent predictor of prostate cancer in men with PSA of 10–50 ng ml−1. Asian Journal of Andrology. 15(3). 409–412. 14 indexed citations
12.
Wan, Ben, Wei Li, Keji Xie, et al.. (2012). Randomized clinical trial evaluating safety and efficacy of propiverine ER 30 mg and tolterodine ER 4 mg in the treatment of overactive bladder. 1 indexed citations
13.
Zhan, Hailun, et al.. (2012). Analysis of the Absence of the Detrusor Muscle in Initial Transurethral Resected Specimens and the Presence of Residual Tumor Tissue. Urologia Internationalis. 89(3). 319–325. 18 indexed citations
14.
Zeng, Jianwen, et al.. (2011). Bladder mechanoreceptor changes after artificial bladder outlet obstruction in the anesthetized rat. Neurourology and Urodynamics. 31(1). 178–184. 10 indexed citations
15.
Tang, Ping, et al.. (2011). Urodynamically diagnosed detrusor hypocontractility: should transurethral resection of the prostate be contraindicated?. International Urology and Nephrology. 44(1). 35–39. 28 indexed citations
16.
Tang, Ping, Wei Du, Keji Xie, et al.. (2011). Characteristics of baseline PSA and PSA velocity in young men without prostate cancer: Racial differences. The Prostate. 72(2). 173–180. 18 indexed citations
17.
18.
Lu, Yanmeng, Jing Zhang, Jiang Qiu, et al.. (2009). [Nephrotoxicity of tacrolimus and preventive effect of diltiazem: experiment with rats].. PubMed. 89(10). 704–8. 5 indexed citations
19.
Tang, Ping, et al.. (2009). Antibacterial therapy improves the effectiveness of prostate cancer detection using prostate-specific antigen in patients with asymptomatic prostatitis. International Urology and Nephrology. 42(1). 13–18. 7 indexed citations
20.
He, Huichan, Weide Zhong, Keji Xie, et al.. (2004). [Effects of potassium citrate delayed preparation in urine PH and citric acid content].. PubMed. 84(21). 1825–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sahyun Pak Breakdown of academic impact, for papers by Yen-Hwa Chang Breakdown of academic impact, for papers by Xiong‐Lin Sun Breakdown of academic impact, for papers by T Zwergel Breakdown of academic impact, for papers by Maximilian Pallauf Breakdown of academic impact, for papers by Mazen A. Ghanem Breakdown of academic impact, for papers by Shinji Kurosaka Breakdown of academic impact, for papers by Kazuaki Machioka Breakdown of academic impact, for papers by Youyi Lu Breakdown of academic impact, for papers by Tomoya Fukawa
Rankless by CCL
2026